课题基金 / 基金详情

Development of targeted therapies to reverse the effects of ageing and disease on wound healing and tissue generation

Development of targeted therapies to reverse the effects of ageing and disease on wound healing and tissue generation
开发靶向疗法以逆转衰老和疾病对伤口愈合和组织生成的影响
批准号:
nhmrc : GNT1054472
负责人:
Mr Michael Findlay
金额:
$39.12万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Early Career Fellowships
财政年份:
2013
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2013-01-01 至 --

项目摘要

项目成果

Mr Michael Findlay的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Despite success with the production of new tissues and organs in laboratory animals, tissue engineering in humans remains elusive. Emerging evidence suggests that ageing and diseases such as diabetes can adversely affect human stem cell regenerative capacity. Characterizing the effects of ageing and disease on stem cells during tissue generation is the first step in reversing these effects, paving the way for the production of new tissues and organs for use in human clinical trials.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterisation of age and comorbidity-related defects in stem cell regenerative capacity during wound healing and adipose tissue engineering to facilitate clinical trials of tissue engineered breast reconstruction.
  • 批准号:
    nhmrc : 1054472
  • 项目类别:
    Early Career Fellowships
  • 资助金额:
    $28.66万
  • 财政年份:
    2013
  • 负责人:
    Mr Michael Findlay
  • 依托单位:
Defining the differentiasome - exploring the determinants of cell differentiation in tissue flap prefabrication
  • 批准号:
    nhmrc : 310627
  • 项目类别:
    NHMRC Postgraduate Scholarships
  • 资助金额:
    $3.5万
  • 财政年份:
    2004
  • 负责人:
    Mr Michael Findlay
  • 依托单位:
国内基金
海外基金
慢性炎症诱发骨丢失的机制及外泌体靶向治疗策略研究
  • 批准号:
    82370889
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    傅德皓
  • 依托单位:
基于再生运动神经路径优化Agrin作用促进损伤神经靶向投射的功能研究
  • 批准号:
    82371373
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    沃雁
  • 依托单位:
小脑浦肯野细胞突触异常在特发性震颤中的作用机制及靶向干预研究
  • 批准号:
    82371248
  • 项目类别:
    面上项目
  • 资助金额:
    47.00万元
  • 批准年份:
    2023
  • 负责人:
    吴逸雯
  • 依托单位:
抑制FGF19/FGFR4信号通路促进肺鳞癌细胞焦亡及免疫增效的机制研究
  • 批准号:
    32100565
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    李凡
  • 依托单位: